The frequency of alcoholism among patients with pain due to terminal cancer

Journal of Pain and Symptom Management
E BrueraM Suarez-Almazor

Abstract

The purpose of this retrospective study was to determine the prevalence of alcoholism among terminally ill cancer patients when assessed by multidisciplinary interviews and by the CAGE Questionnaire. We reviewed the charts of 100 consecutive patients assessed by a multidisciplinary team for the presence of alcoholism during 1989, and 100 consecutive patients assessed by the CAGE Questionnaire during 1992. Alcoholism was diagnosed in 28/100 patients during 1989 (28%) and 18/66 patients during 1992 (27%). Thirty-four patients were unable to complete the CAGE Questionnaire in 1992 because of sedation or cognitive impairment; six of these patients (17%) were found to be alcoholics after multidisciplinary assessment. Only 9/28 (32%) and 8/24 (33%) patients diagnosed as alcoholics during 1989 and 1992, respectively, had been previously diagnosed as alcoholics according to the medical charts. The mean equivalent daily dose of morphine during admission and on Day 2 during 1992 were 153 +/- 193 mg and 183 +/- 198 for alcoholic patients, versus 58 +/- 80 and 70 +/- 79 mg for nonalcoholics (P = 0.06 and 0.03, respectively). The maximal dose of opioid and the pain intensity during admission, however, were not significantly different betwee...Continue Reading

References

Jun 1, 1991·The American Journal of Drug and Alcohol Abuse·N el-GuebalyS Koensgen
Jan 1, 1993·The Psychiatric Quarterly·P A Mansky
Apr 1, 1993·Journal of Pain and Symptom Management·S McCorquodaleE Bruera

❮ Previous
Next ❯

Citations

Mar 6, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Robin L Fainsinger, Cheryl L Nekolaichuk
May 16, 2012·Current Pain and Headache Reports·Shalini Dalal, Eduardo Bruera
Apr 13, 2000·Journal of Pain and Symptom Management·S D Passik, D E Theobald
Oct 6, 2000·Journal of Pain and Symptom Management·K K Kuebler, E Bruera
Oct 22, 2005·Journal of Palliative Medicine·Ahmed Elsayem, Eduardo Bruera
Jun 7, 2006·Journal of Palliative Medicine·Susan D Block
Sep 16, 2008·Journal of Palliative Medicine·Henrique A ParsonsEduardo Bruera
May 7, 2009·Journal of Palliative Medicine·Pippa Hawley
May 7, 2009·Journal of Palliative Medicine·Gary M ReisfieldGeorge R Wilson
Jan 8, 2013·Journal of Palliative Medicine·Leslie J BlackhallJoshua S Barclay
Sep 26, 2000·The American Journal of Nursing·B Henderson-Martin
Nov 19, 2002·The American Journal of Nursing·Judith A Paice
Jan 24, 2006·The Clinical Journal of Pain·Steven D PassikRussell K Portenoy
Sep 21, 2013·The Cancer Journal·Shalini DalalEduardo Bruera
Jan 1, 1997·Acta Anaesthesiologica Scandinavica·E Bruera, P Lawlor
Jun 5, 2002·Alcoholism, Clinical and Experimental Research·Nomelí P NúñezGary G Meadows
Jan 21, 2004·CNS Drugs·Steven D Passik, Kenneth L Kirsh
Feb 25, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Joshua S BarclayLeslie J Blackhall
Feb 15, 2014·Palliative & Supportive Care·Jung Hye KwonEduardo Bruera
Nov 26, 2013·Best Practice & Research. Clinical Anaesthesiology·Joseph Arthur, Eduardo Bruera
Jun 19, 2015·Expert Opinion on Drug Safety·Daniel KrashinJane Ballantyne
Dec 26, 2015·Journal of Pain and Symptom Management·Yu Jung KimEduardo Bruera
Jun 18, 2011·Journal of Pain and Symptom Management·Julie W Childers, Robert M Arnold
Dec 24, 2003·Alcoholism, Clinical and Experimental Research·Mark W KimpelJanice C Froehlich
Jan 5, 2005·The Journal of Pain : Official Journal of the American Pain Society·Mark Sullivan, Betty Ferrell
Jan 1, 1996·Cancer Treatment Reviews·E Bruera
Jul 1, 2014·Journal of Pain and Symptom Management·Sebastiano MercadanteUNKNOWN Home Care-Italy Group (HOCAI)
Nov 13, 2014·Pain Practice : the Official Journal of World Institute of Pain·Sebastiano MercadanteAlessandra Casuccio
Aug 25, 2015·Journal of Palliative Medicine·Paul D TanLeslie J Blackhall
Oct 9, 2014·Postgraduate Medicine·Allan GordonSteven D Passik
Apr 30, 2015·Journal of Palliative Medicine·Jung Hye KwonEduardo Bruera
Apr 27, 2016·Journal of Ethnicity in Substance Abuse·Sumedha Chhatre, Ravishankar Jayadevappa
Jan 17, 2012·Pain·Eduardo Bruera
Apr 5, 2008·Clinics in Geriatric Medicine·Kenneth L Kirsh, Howard S Smith
Jul 11, 2016·Journal of Geriatric Oncology·Ravishankar Jayadevappa, Sumedha Chhatre
Feb 6, 1998·Psycho-oncology·J C Lundberg, S D Passik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.